Counsel Corporation: SAGE BioPharma, Inc. Expands its Position in the Infertility Market Through the Acquisition of Fertility Technologies, Inc.TORONTO--(BUSINESS WIRE)--March 18, 1999--Counsel Corp.(NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CXSN) (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :CXS CXS Coherent X-Ray Scattering .) SAGE BioPharma, Inc. (SAGE), a subsidiary of Counsel Corporation (TSE: CXS; Nasdaq: CXSN) focused on the infertility market announced today that it has completed the acquisition of substantially all of the assets of Fertility Technologies, Inc. ("FTI FTI Free thyroxine index, see there "), a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of the Zonagen, Inc. (Nasdaq: ZONA; Pacific: ZNG). The terms of the transaction were not disclosed. "The FTI acquisition positions SAGE as the most complete provider of products to the Assisted Reproductive Techniques (ART) community. SAGE's product line includes diagnostics, advanced ART culture media, instruments and medical devices. This acquisition advances SAGE's plan to be a leader in the infertility arena," said Morris Perlis, President of Counsel Corporation. "SAGE BioPharma is a company dedicated to becoming the preeminent provider of a broad range of infertility products targeted to the needs of both practitioners and patients," according to Dr. James Posillico, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "SAGE's strategy is to provide an integrated product line and superior customer service to the ART center. The acquisition of FTI, coupled with the previous strategic acquisitions of other ART focused companies, clearly enhances SAGE's position in this market by providing additional key products and a national distribution capability," Posillico said. Counsel Corporation has been active in the healthcare sector since 1983. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion